Preventive effect of 20 mEq and 8 mEq magnesium supplementation on cisplatin-induced nephrotoxicity: a propensity score–matched analysis
- 05.01.2022
- Original Article
Erschienen in:
- Verfasst von
- Takanori Miyoshi
- Toshinobu Hayashi
- Miyuki Uoi
- Fuyuki Omura
- Kyouichi Tsumagari
- Sachi Maesaki
- Chiaki Yokota
- Takafumi Nakano
- Takashi Egawa
- Erschienen in
- Supportive Care in Cancer | Ausgabe 4/2022
Abstract
Purpose
The protective effect of magnesium (Mg) supplementation against cisplatin (CDDP)-induced nephrotoxicity has been widely described; however, the optimal dose of Mg supplementation is unclear. The aim of this study was to investigate whether 20 mEq of Mg supplementation is more effective than 8 mEq Mg in preventing CDDP-induced nephrotoxicity, as well as the associated risk factors, in cancer patients treated with CDDP-based chemotherapy.
Methods
Pooled data of 272 patients receiving 20 mEq or 8 mEq Mg supplementation to CDDP-based chemotherapy from a multicenter, retrospective, observational study were compared using propensity score matching. Separate multivariate logistic regression analyses were used to identify the risk factors for renal failure induced by each treatment dose.
Results
There was no significant difference in the incidence of nephrotoxicity between the 8 mEq and 20 mEq groups (P = 0.926). There was also no significant difference in the severity of nephrotoxicity, elevated serum creatinine levels, and decreased estimated creatinine clearance levels between the two groups. Cardiac disease and albumin levels were identified as independent risk factors for CDDP-induced nephrotoxicity.
Conclusion
We did not find an advantage of 20 mEq over 8 mEq Mg supplementation in terms of a preventive effect against CDDP-induced nephrotoxicity. The optimal dose of Mg supplementation for the prevention of CDDP-induced nephrotoxicity remains unknown, and further studies are warranted.
Anzeige
- Titel
- Preventive effect of 20 mEq and 8 mEq magnesium supplementation on cisplatin-induced nephrotoxicity: a propensity score–matched analysis
- Verfasst von
-
Takanori Miyoshi
Toshinobu Hayashi
Miyuki Uoi
Fuyuki Omura
Kyouichi Tsumagari
Sachi Maesaki
Chiaki Yokota
Takafumi Nakano
Takashi Egawa
- Publikationsdatum
- 05.01.2022
- Verlag
- Springer Berlin Heidelberg
- Erschienen in
-
Supportive Care in Cancer / Ausgabe 4/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339 - DOI
- https://doi.org/10.1007/s00520-021-06790-w
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
